Loading...
Skin problems and EGFR-tyrosine kinase inhibitor
Epidermal growth factor receptor inhibition is a good target for the treatment of lung, colon, pancreatic and head and neck cancers. Epidermal growth factor receptor-tyrosine kinase inhibitor was first approved for the treatment of advanced lung cancer in 2002. Epidermal growth factor receptor-tyros...
Saved in:
| Published in: | Jpn J Clin Oncol |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4886131/ https://ncbi.nlm.nih.gov/pubmed/26826719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyv207 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|